The Bactericidal Fatty Acid Mimetic 2CCA-1 Selectively Targets Pneumococcal Extracellular Polyunsaturated Fatty Acid
Elisabeth Reithuber1, Priyanka Nannapaneni1, Olena Rzhepishevska2
1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Insights
A novel compound, 2CCA-1, effectively lyses Streptococcus pneumoniae by disrupting fatty acid metabolism. Resistance emerges through mutations in fakB3 or fabT, revealing a link between host fatty acid uptake and bacterial synthesis.
Area of Science:
- Microbiology
- Biochemistry
- Drug Discovery
Background:
- Streptococcus pneumoniae causes significant global disease burden, necessitating novel therapeutic strategies.
- Targeting bacterial fatty acid biosynthesis offers a promising avenue for antibiotic development.
- The nasopharynx serves as the primary reservoir for S. pneumoniae.
Purpose of the Study:
- To identify narrow-spectrum antibacterial agents targeting S. pneumoniae.
- To elucidate the mechanism of action and resistance of novel compounds.
- To explore the interplay between host fatty acid uptake and bacterial fatty acid synthesis.
Main Methods:
- Screening for small molecules inducing autolysin-mediated lysis of S. pneumoniae.
- Structure-activity relationship analysis of identified compounds.
- Investigating resistance mechanisms through genetic mutation analysis (fakB3, fabT).
- Lipidomic analysis to identify metabolic products of the compound.
Main Results:
- 2CCA-1, an alkylated dicyclohexyl carboxylic acid, potently induces S. pneumoniae lysis.
- Resistance to 2CCA-1 is associated with mutations in fakB3 (host fatty acid uptake) and fabT (endogenous fatty acid synthesis regulation).
- 2CCA-1 is metabolized as a fatty acid via FakB3, incorporated into toxic phospholipid species, leading to bacterial death.
- A regulatory connection between host polyunsaturated fatty acid metabolism and endogenous fatty acid synthesis in S. pneumoniae was identified.
Conclusions:
- 2CCA-1 represents a potent bactericidal agent against S. pneumoniae, acting through a novel mechanism involving fatty acid metabolism.
- Targeting FakB3 offers a potential narrow-spectrum strategy against S. pneumoniae and related Lactobacillales.
- Understanding the regulation of fatty acid homeostasis is crucial for developing effective antimicrobial therapies.
Abstract:
Streptococcus pneumoniae, a major cause of pneumonia, sepsis, and meningitis worldwide, has the nasopharynges of small children as its main ecological niche. Depletion of pneumococci from this niche would reduce the disease burden and could be achieved using small molecules with narrow-spectrum antibacterial activity. We identified the alkylated dicyclohexyl carboxylic acid 2CCA-1 as a potent inducer of autolysin-mediated lysis of S. pneumoniae, while having low activity against Staphylococcus aureus 2CCA-1-resistant strains were found to have inactivating mutations in fakB3, known to be required for uptake of host polyunsaturated fatty acids, as well as through inactivation of the transcriptional regulator gene fabT, vital for endogenous, de novo fatty acid synthesis regulation. Structure activity relationship exploration revealed that, besides the central dicyclohexyl group, the fatty acid-like structural features of 2CCA-1 were essential for its activity. The lysis-inducing activity of 2CCA-1 was considerably more potent than that of free fatty acids and required growing bacteria, suggesting that 2CCA-1 needs to be metabolized to exert its antimicrobial activity. Total lipid analysis of 2CCA-1 treated bacteria identified unique masses that were modeled to 2CCA-1 containing lysophosphatidic and phosphatidic acid in wild-type but not in fakB3 mutant bacteria. This suggests that 2CCA-1 is metabolized as a fatty acid via FakB3 and utilized as a phospholipid building block, leading to accumulation of toxic phospholipid species. Analysis of FabT-mediated fakB3 expression elucidates how the pneumococcus could ensure membrane homeostasis and concurrent economic use of host-derived fatty acids.IMPORTANCE Fatty acid biosynthesis is an attractive antibiotic target, as it affects the supply of membrane phospholipid building blocks. In Streptococcus pneumoniae, it is not sufficient to target only the endogenous fatty acid synthesis machinery, as uptake of host fatty acids may bypass this inhibition. Here, we describe a small-molecule compound, 2CCA-1, with potent bactericidal activity that upon interactions with the fatty acid binding protein FakB3, which is present in a limited number of Gram-positive species, becomes metabolized and incorporated as a toxic phospholipid species. Resistance to 2CCA-1 developed specifically in fakB3 and the regulatory gene fabT These mutants reveal a regulatory connection between the extracellular polyunsaturated fatty acid metabolism and endogenous fatty acid synthesis in S. pneumoniae, which could ensure balance between efficient scavenging of host polyunsaturated fatty acids and membrane homeostasis. The data might be useful in the identification of narrow-spectrum treatment strategies to selectively target members of the Lactobacillales such as S. pneumoniae.


